| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5899995 | Diabetes Research and Clinical Practice | 2013 | 4 Pages |
Abstract
We examined the effects of atorvastatin on urinary podocyte excretion. Thirteen patients with type 2 diabetes receiving 2.5Â mg of rosuvastatin were recruited and the medication was switched to 10Â mg of atorvastatin for a 24-week period. With the switch to atorvastatin, the urinary excretion of podocytes was significantly reduced.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Minoru Takemoto, Takahiro Ishikawa, Shunichiro Onishi, Emiko Okabe, Ryoichi Ishibashi, Peng He, Kazuki Kobayashi, Masaki Fujimoto, Harukiyo Kawamura, Koutaro Yokote,